References
- Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977; 62: 707
- Kannel W. B., Castelli W. P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 1979; 90: 235
- Nikkilä E. A. High density lipoproteins in relation to endocrine factors. Lipoprotein metabolism and endocrine regulation, L. W. Hessel, H. M. J. Krans. Elsevier/Biomed Press, Amsterdam 1979; 13
- Wallentin L., Larsson-Cohn U. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids. Acta Endocrinol (Copenh) 1977; 86: 597
- Tikkanen M. J., Kuusi T., Vartianen E., Nikkilä E. A. Treatment of postmenopausal hypercholesterolaemia with estradiol. Acta Obstet Gynecol Scand 1979, Suppl 88: 83
- Hirvonen E., Mälkönen M., Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Eng J Med 1981; 304: 560
- Fåhraeus L., Larsson-Cohn U., Wallentin L. L-norgestrel and progesterone have different effects on plasma lipoproteins. Eur J Clin Invest 1983; 13: 447
- Allen J. K., Fraser I. S. Cholesterol, high density lipoprotein and danazol. J Clin Endocrinol Metab 1981; 53: 149
- Mälkönen M., Hirvonen E., Manninen V. Effect of danazol and lynestrenol on serum lipoproteins in endometriosis. Clin Pharmacol Ther 1980; 28: 502
- Luciano A. A., Hauser K. S., Chapler F. K., Davis W. A., Wallace R. B. Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis. Am J Obstet Gynecol 1983; 145: 422
- Wallentin L., Fåhraeus L. HDL3 and HDL2 detemination by a combined ultracentrifugation and precipitation procedure. Clin Chim Acta 1981; 116: 199
- Nilsson B., Södergård R., Damber M. G., von Schoultz B. Danazol and gestagen displacement of testosterone and influence on sex hormone binding globulin capacity. Fertil Steril 1982; 38: 48
- Fraser I. S., Allen J. K. Danazol and cholesterol metabolism. Lancet 1979; i: 931
- Tikkanen M. J., Nikkilä E. A., Kuusi T., Sipinen S. Reduction of plasma high-density lipoprotein, cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment. Clin Chim Acta 1981; 115: 63